Britain Eakin

A California federal judge on Monday refused to hand a quick win to GoPro Inc. in a spat with Contour IP Holding LLC over digital camera technology, rejecting GoPro’s arguments that the pair of patents it’s accused of infringing fail the first step of the U.S. Supreme Court’s Alice test.

A California federal judge has refused to toss Lyft Inc.’s suit claiming that it does not infringe a series of Quartz Auto Technologies patents covering GPS and autonomous vehicle and device locator technology, finding that the court has jurisdiction over the patent owner.

The owner of a Los Angeles vape company won a ruling from a split Federal Circuit panel on Wednesday that found a rival didn’t give him enough notice that his e-cigarettes allegedly infringed a vape patent and wiped out a jury’s nearly $864,000 verdict against him.

Cisco is asking the Federal Circuit to throw out a $2.7 billion damages award against it after a lower court ruled that the networking giant infringed four Centripetal Networks patents, saying the judge should have recused himself because his wife owned Cisco stock.

Pfizer and BioNTech have received the full green light from the federal government for their COVID-19 vaccine, more than eight months after the U.S. Food and Drug Administration gave the treatment emergency use authorization.

A Delaware federal judge on Thursday ruled in favor of AbbVie and Janssen Biotech Inc. in their 2019 suit against Alvogen over its planned generic version of the blockbuster cancer drug Imbruvica, holding that all four patents in the case were not shown to be invalid.

Juniper Networks has persuaded the Patent Trial and Appeal Board to review a patent it’s been accused of infringing in the Western District of Texas by WSOU Investments LLC, with the board rejecting the latter’s bid for denial in light of a July 2022 trial date in the parallel case.

The Federal Circuit on Wednesday ruled that prolific inventor Gilbert Hyatt, who sued the U.S. Patent and Trademark Office for rejecting his patent applications, doesn’t need to repay over a half-million dollars the agency spent on expert witnesses, thanks to a recent U.S. Supreme Court ruling.

The Patent Trial and Appeal Board has agreed to review an Amgen patent covering its blockbuster anti-infection drug Neulasta in a challenge brought by Pfizer and Hospira, rejecting Amgen’s argument that the board should deny inter partes review based on the state of parallel litigation in Delaware.

The Federal Circuit on Tuesday vacated parts of two mixed Patent Trial and Appeal Board rulings on two Ironburg Inventions Ltd. video game controller patents, holding that the board wrongly disqualified a printed publication submitted by challenger Valve Corp. as prior art.

In the wake of the U.S. Supreme Court’s Arthrex decision, the U.S. Patent and Trademark Office director has been asked by Arthrex Inc. itself to review a 2017 ruling invalidating two claims in a suture patent that were canceled by the USPTO in June.

ResMan LLC asked a Texas federal judge Thursday to award it $14.6 million in attorney fees and costs on top of a final judgment of $62.4 million that the apartment management software company won in a trade secrets dispute with a former customer.

The Federal Circuit on Friday affirmed a district court ruling that Apotex and Mylan infringed patents on Teva’s cancer drug Bendeka and failed to show the patents were invalid, a decision that could stymie planned generics until 2031 when the last patent expires.

U.S. District Judge Alan Albright has shipped a case to Delaware after finding that SmileDirectClub’s decision to file a patent infringement suit against Candid Care in the Western District of Texas was an act of “blatant forum shopping.”

The Brazilian Senate has passed a bill that will allow the country’s president to temporarily waive patent rights and grant compulsory licenses for COVID-19 vaccines and medicines in light of the public health emergency spurred by the global pandemic.

Judge Alan D. Albright of the U.S. District Court for the Western District of Texas has rejected Intel’s request for a new trial after a jury came down with a $2.18 billion verdict against it for infringing VLSI Technology LLC’s computer chip patents, one of the largest patent verdicts in history.

Pharmaceutical giant AstraZeneca is the latest to say the Patent Trial and Appeal Board’s policy of rejecting patent reviews based on district court litigation violates the law, arguing in a new lawsuit that applying the policy to post grant reviews renders those procedures “meaningless.”

A Texas federal judge denied a motion Wednesday from Karya Property Management and software developer Expedien for judgment as a matter of law in their bid to undo ResMan LLC’s $152 million jury win, ruling that the jury verdict finding that Karya misappropriated trade secrets to make competing soft…

The Patent Trial and Appeal Board has found that claims in two polymer patents that cover a hemophilia treatment developed by Nektar Therapeutics are obvious in light of a collection of prior art.

Apple has asked the U.S. Supreme Court to decide whether the Federal Circuit has the authority to review decisions in which the Patent Trial and Appeal Board exercises its discretion to deny patent reviews in light of parallel district court litigation, marking the first time the justices have been …